Valentina Santo
机构：Harvard University, Dana-Farber Cancer Institute · ORCID：0009-0006-7587-9445
发表论文 67 篇 · 总被引 156 次 · h-index 7
代表论文
- Host-related Determinants of Response to Immunotherapy in Non-small Cell Lung Cancer: The Interplay of Body Composition, Metabolism, Sex and Immune Regulation (2025 · Current Oncology Reports · 被引 7)
- Long-term outcomes from pembrolizumab monotherapy in patients with advanced NSCLC, PD-L1 expression ≥ 50 %, and poor performance status: Transformer-based AI to characterize prognostic complexity (2025 · Lung Cancer · 被引 1)
- P3.12.63 MTAPloss Is Frequent and Potentially Targetable With PRMT5 Inhibitors in Oncogene-Driven NSCL (2025 · Journal of Thoracic Oncology · 被引 1)
- Impact of STK11 / KEAP1 / SMARCA4 co-mutations in RAS-activated KRAS wild-type metastatic NSCLC treated with immune checkpoint inhibitors. (2026 · Journal of Clinical Oncology)
- Osimertinib-Induced Lung Injury and Treatment Rechallenge: Clinical Insights From a Case Report With a Comprehensive Literature Review (2025 · Clinical Lung Cancer)
- Supplementary Figure 5 from First-Line MET Tyrosine Kinase Inhibitors versus Immunotherapy ± Chemotherapy for Patients with MET Exon 14 Skipping Mutant Metastatic NSCLC (2025)